Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysisB.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, Matti A. Rookus et al.|International Journal of Cancer|2014Cited by 215
Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndromeMarry H. Nieuwenhuis, Hans F. A. Vasen, C. Marleen Kets et al.|Familial Cancer|2013Cited by 163
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Matti A. Rookus, Fergus J. Couch et al.|Breast Cancer Research|2011Cited by 118
Is colorectal surveillance indicated in patients with PTEN mutations?Marry H. Nieuwenhuis, Hans F. A. Vasen, C. Marleen Kets et al.|Colorectal Disease|2012Cited by 34
Psychology and counsellingH. Van Parys, Salvatore Gullo, V. Soderstrom - Anttila et al.|Human Reproduction|2013Cited by 1